trending Market Intelligence /marketintelligence/en/news-insights/trending/VZeamjBU1diY9981SH0krg2 content esgSubNav
In This List

Rosetta Genomics receives extension to regain compliance with Nasdaq

Blog

Insight Weekly: Unease roils markets; US likely to slip into recession; firms' cash ratios fall

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch


Rosetta Genomics receives extension to regain compliance with Nasdaq

Nasdaq granted Rosetta Genomics Ltd. an extension to regain compliance with the exchange's listing requirement.

Under the extension, Rosetta Genomics must close its previously announced acquisition by Genoptix Inc. by April 23, 2018.

In case the deal does not go through, the company must raise equity to comply with the exchange's requirement.